HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insertional inactivation of the WT1 gene in tumour cells from a patient with WAGR syndrome.

Abstract
The WT1 gene was analysed using DNA from a Wilms' tumour derived from a patient with the WAGR syndrome using single strand conformation polymorphism analysis and polymerase chain reaction sequencing. A 14-bp insertion was found in the intron part of the splice donor site of exon 7 and was a tandem duplication of an upstream exon sequence. This mutation would be expected to disrupt the correct processing of the WT1 mRNA and is predicted to result in a non-functional protein. This observation further supports the role of WT1 in Wilms' tumorigenesis in patients with constitutional 11p13 deletions.
AuthorsA Santos, L Osorio-Almeida, P N Baird, J M Silva, M G Boavida, J Cowell
JournalHuman genetics (Hum Genet) Vol. 92 Issue 1 Pg. 83-6 (Aug 1993) ISSN: 0340-6717 [Print] Germany
PMID8396067 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA
Topics
  • Abnormalities, Multiple (genetics)
  • Alleles
  • Base Sequence
  • Child, Preschool
  • Chromosomes, Human, Pair 11
  • DNA
  • Female
  • Gene Deletion
  • Genes, Wilms Tumor
  • Humans
  • Molecular Sequence Data
  • Mutation
  • Polymerase Chain Reaction
  • Syndrome
  • Tumor Cells, Cultured
  • Wilms Tumor (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: